MeSH tree: D02.442
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage of patients successfully completed both regimens and suffered few adverse side effects. A team ...
Feb 10, 2026
0
18
A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and half of the patients die. ...
Dec 17, 2025
0
13
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.
Jul 11, 2025
0
39
Kansas health officials are fighting the largest tuberculosis (TB) outbreak in recent U.S. history, with 67 confirmed cases since the new year began.
Jan 28, 2025
0
20
Tuberculosis, the main cause of death due to a single pathogen globally, causes more than 1.5 million deaths each year. New research from the University of Cincinnati finds that being in prison or being a former prisoner ...
Feb 9, 2024
0
58
A proportion of patients with drug-resistant tuberculosis (TB) receive ineffective treatment due to misdiagnosis by rapid molecular tests, according to a genomic analysis carried out in southern Mozambique and co-led by the ...
Dec 4, 2023
0
43
A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George's, University of London. Results have been ...
Aug 29, 2023
0
46
The U.S. Preventive Services Task Force (USPSTF) recommends screening people at increased risk for latent tuberculosis infection (LTBI). This recommendation forms a final recommendation statement published in the May 2 issue ...
May 2, 2023
0
31
The U.S. Preventive Services Task Force (USPSTF) recommends screening for latent tuberculosis infection (LTBI) in populations at increased risk. This recommendation forms the basis of a draft recommendation statement, published ...
Nov 23, 2022
0
65
